Credit Suisse Ag Aerie Pharmaceuticals Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$6.37 - $15.23 $851,006 - $2.03 Million	133,596 Added 430.25%	164,647 $2.49 Million
Q2 2022 Aug 12, 2022	SELL	$4.95 - $9.16 $1,465 - $2,711	-296 Reduced 0.94%	31,051 $233,000
Q1 2022 May 16, 2022	BUY	$5.64 - $9.8 $11,595 - $20,148	2,056 Added 7.02%	31,347 $284,000
Q4 2021 Feb 14, 2022	SELL	$7.02 - $13.33 $90,712 - $172,250	-12,922 Reduced 30.61%	29,291 $205,000
Q3 2021 Nov 12, 2021	BUY	$11.32 - $16.63 $37,242 - $54,712	3,290 Added 8.45%	42,213 $482,000
Q2 2021 Aug 16, 2021	SELL	$15.16 - $18.97 $151,994 - $190,193	-10,026 Reduced 20.48%	38,923 $624,000
Q1 2021 May 14, 2021	BUY	$13.12 - $20.9 $90,816 - $144,669	6,922 Added 16.47%	48,949 $874,000
Q4 2020 Feb 12, 2021	BUY	$9.12 - $14.49 $106,804 - $169,692	11,711 Added 38.63%	42,027 $568,000
Q3 2020 Nov 13, 2020	SELL	$10.46 - $14.46 $4.01 Million - $5.55 Million	-383,700 Reduced 92.68%	30,316 $357,000
Q2 2020 Aug 12, 2020	BUY	$12.0 - $16.13 $4.59 Million - $6.17 Million	382,740 Added 1223.75%	414,016 $6.11 Million
Q1 2020 May 13, 2020	BUY	$11.84 - $25.52 $4,274 - $9,212	361 Added 1.17%	31,276 $422,000
Q4 2019 Feb 12, 2020	SELL	$17.72 - $25.1 $2.94 Million - $4.17 Million	-166,126 Reduced 84.31%	30,915 $747,000
Q3 2019 Nov 12, 2019	BUY	$18.41 - $28.0 $897,542 - $1.37 Million	48,753 Added 32.88%	197,041 $3.79 Million
Q2 2019 Aug 14, 2019	BUY	$28.97 - $48.21 $3.36 Million - $5.6 Million	116,154 Added 361.47%	148,288 $4.38 Million
Q1 2019 May 14, 2019	BUY	$36.32 - $49.25 $84,480 - $114,555	2,326 Added 7.8%	32,134 $1.53 Million
Q4 2018 Feb 13, 2019	SELL	$33.0 - $60.04 $7.11 Million - $12.9 Million	-215,538 Reduced 87.85%	29,808 $1.08 Million
Q3 2018 Nov 13, 2018	BUY	$56.15 - $73.9 $463,967 - $610,635	8,263 Added 3.49%	245,346 $15.1 Million
Q2 2018 Aug 14, 2018	SELL	$47.85 - $70.45 $4.46 Million - $6.56 Million	-93,177 Reduced 28.21%	237,083 $16 Million
Q1 2018 May 15, 2018	BUY	$51.15 - $61.0 $7.71 Million - $9.2 Million	150,757 Added 83.99%	330,260 $17.9 Million
Q4 2017 Feb 14, 2018	BUY	$50.85 - $65.1 $3.19 Million - $4.08 Million	62,714 Added 53.7%	179,503 $10.7 Million
Q3 2017 Nov 14, 2017	BUY	$48.6 - $60.1 $2.95 Million - $3.65 Million	60,678 Added 108.14%	116,789 $5.68 Million
Q2 2017 Aug 14, 2017	BUY	N/A	56,111	56,111 $2.95 Million

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account